Body Mass and Smoking Are Modifiable Risk Factors for Recurrent Bladder Cancer

被引:81
作者
Wyszynski, Asaf [1 ,2 ]
Tanyos, Sam A. [1 ]
Rees, Judy R. [1 ]
Marsit, Carmen J. [1 ,2 ]
Kelsey, Karl T. [3 ,4 ]
Schned, Alan R. [5 ]
Pendleton, Eben M. [1 ]
Celaya, Maria O. [1 ]
Zens, Michael S. [1 ]
Karagas, Margaret R. [1 ]
Andrew, Angeline S. [1 ]
机构
[1] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Dept Community & Family Med, Lebanon, NH USA
[2] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Program Expt & Mol Med, Hanover, NH USA
[3] Brown Univ, Ctr Environm Hlth & Technol, Dept Epidemiol, Providence, RI 02912 USA
[4] Brown Univ, Ctr Environm Hlth & Technol, Dept Pathol & Lab Med, Providence, RI 02912 USA
[5] Geisel Sch Med Dartmouth, Dept Pathol, Lebanon, NH USA
关键词
bladder cancer; urothelial cell carcinoma; obesity; smoking; body mass index; recurrence; BREAST-CANCER; RADICAL CYSTECTOMY; PHYSICAL-ACTIVITY; CIGARETTE-SMOKE; OBESITY; EPIDEMIOLOGY; PROSTATE; HEALTH; INDEX; MEN;
D O I
10.1002/cncr.28394
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDIn the Western world, bladder cancer is the fourth most common cancer in men and the eighth most common in women. Recurrences frequently occur, and continued surveillance is necessary to identify and treat recurrent tumors. Efforts to identify risk factors that are potentially modifiable to reduce the rate of recurrence are needed. METHODSCigarette smoking behavior and body mass index were investigated at diagnosis for associations with bladder cancer recurrence in a population-based study of 726 patients with bladder cancer in New Hampshire, United States. Patients diagnosed with non-muscle invasive urothelial cell carcinoma were followed to ascertain long-term prognosis. Analysis of time to recurrence was performed using multivariate Cox regression models. RESULTSSmokers experienced shorter time to recurrence (continuing smoker hazard ratio [HR]=1.51, 95% confidence interval [CI]=1.08-2.13). Although being overweight (body mass index >24.9 kg/m(2)) at diagnosis was not a strong independent factor (HR=1.33, 95% CI=0.94-1.89), among continuing smokers, being overweight more than doubled the risk of recurrence compared to smokers of normal weight (HR=2.67, 95% CI=1.14-6.28). CONCLUSIONSThese observational results suggest that adiposity is a risk factor for bladder cancer recurrence, particularly among tobacco users. Future intervention studies are warranted to evaluate whether both smoking cessation and weight reduction strategies reduce bladder tumor recurrences. Cancer 2014;120:408-414. (c) 2013 American Cancer Society.
引用
收藏
页码:408 / 414
页数:7
相关论文
共 37 条
[1]   Bladder cancer SNP panel predicts susceptibility and survival [J].
Andrew, Angeline S. ;
Gui, Jiang ;
Sanderson, Arthur C. ;
Mason, Rebecca A. ;
Morlock, Elaine V. ;
Schned, Alan R. ;
Kelsey, Karl T. ;
Marsit, Carmen J. ;
Moore, Jason H. ;
Karagas, Margaret R. .
HUMAN GENETICS, 2009, 125 (5-6) :527-539
[2]   Does smoking status influence the prognosis of bladder cancer? A systematic review [J].
Aveyard, P ;
Adab, P ;
Cheng, KK ;
Wallace, DMA ;
Hey, K ;
Murphy, MFG .
BJU INTERNATIONAL, 2002, 90 (03) :228-239
[3]   Androgen receptor signalling in prostate: Effects of stromal factors on normal and cancer stem cells [J].
Berry, Paul A. ;
Maitland, Norman J. ;
Collins, Anne T. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 288 (1-2) :30-37
[4]   The health economics of bladder cancer - A comprehensive review of the published literature [J].
Botteman, MF ;
Pashos, CL ;
Redaelli, A ;
Laskin, B ;
Hauser, R .
PHARMACOECONOMICS, 2003, 21 (18) :1315-1330
[5]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[6]   Hydroquinone, a major component in cigarette smoke, reduces IFN-γ production in antigen-primed lymphocytes [J].
Choi, Jin Myung ;
Cho, Young-Chang ;
Cho, Won Jea ;
Kim, Tae Sung ;
Kang, Bok Yun .
ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (03) :337-341
[7]   Leptin Signaling in Breast Cancer: An Overview [J].
Cirillo, Donatella ;
Rachiglio, Anna Maria ;
la Montagna, Raffaele ;
Giordano, Antonio ;
Normanno, Nicola .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (04) :956-964
[8]   The Role of Obesity in Cancer Survival and Recurrence [J].
Demark-Wahnefried, Wendy ;
Platz, Elizabeth A. ;
Ligibel, Jennifer A. ;
Blair, Cindy K. ;
Courneya, Kerry S. ;
Meyerhardt, Jeffrey A. ;
Ganz, Patricia A. ;
Rock, Cheryl L. ;
Schmitz, Kathryn H. ;
Wadden, Thomas ;
Philip, Errol J. ;
Wolfe, Bruce ;
Gapstur, Susan M. ;
Ballard-Barbash, Rachel ;
McTiernan, Anne ;
Minasian, Lori ;
Nebeling, Linda ;
Goodwin, Pamela J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (08) :1244-1259
[9]  
Dirat B, 2010, ENDOCR DEV, V19, P45, DOI 10.1159/000316896
[10]  
Fleshner N, 1999, CANCER, V86, P2192